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 Abstract
Osteoporosis is the most common metabolic bone disease and goes largely undiagnosed throughout the world, due to the inaccessibility of 
DXA machines. Multivariate analyses of serum bone turnover markers were evaluated in 226 Orange County, California, residents with the 
intent to determine if serum osteocalcin and serum pyridinoline cross-links could be used to detect the onset of osteoporosis as effectively as 
a DXA scan. Descriptive analyses of the demographic and lab characteristics of the participants were performed through frequency, means 
and standard deviation estimations. We implemented logistic regression modeling to find the best classification algorithm for osteoporosis. 
All calculations and model building steps were carried out using R statistical language. Through these analyses, a mathematical algorithm 
with diagnostic potential was created. This algorithm showed a sensitivity of 1.0 and a specificity of 0.83, with an area under the Receiver 
Operating Characteristic curve of 0.93, thus demonstrating a high predictability for osteoporosis. Our intention is for this algorithm to be 
used to evaluate osteoporosis in locations where access to DXA scanning is scarce.
Introduction
Bone remodeling is a dynamic and life-long process that 
involves the resorption of mineralized bone by osteoclasts 
and the formation of bone matrix by osteoblasts [1]. Skeletal 
integrity is maintained through the systemic and local 
regulation of this bone remodeling process [2]. Among healthy 
adults, this process maintains parity between bone resorption 
and bone formation. Osteoporosis is caused by a disequilibrium 
of the bone remodeling process, leading to weak and porous 
bones [2]. Osteoporosis impedes an individual’s life with a 
host of disorders and body changes that include, but are not 
limited to, intervertebral bone mass loss leading to reduced 
height, compromised posture, chronic pain, limited mobility 
and, most severely, bone fractures [3]. It is by far the most 
common metabolic bone disease, affecting over 200 million 
people worldwide and often has the secondary manifestation 
of being an economic burden on the individual and society 
[4]. Almost one quarter of osteoporosis diagnoses (44 million) 
come solely from the United States of America, a country that 
contributes to only 4.3% of the global population [5].  
The most definitive method of diagnosing osteoporosis is 
through the use of Dual-energy X-ray Absorptiometry (DXA) 
[6]. Currently, DXA scanning is known as the gold standard 
for measuring bone mineral density (BMD), in which a low 
BMD is indicative of osteoporosis [7]. DXA findings are 
measured in mass per area (g/cm3) and use the average of an 
individual’s BMD from various body locations to generate a 
T-score and a Z-score [6]. Based on these statistical measures 
of variance from age-adjusted means, one can determine if 
they have normal bone density, below-normal bone density 
(a condition known as osteopenia) or are osteoporotic [7]. 
Without DXA scanning, individuals are unaware of this 
bone disease until they are faced with a fragility fracture [8]. 
The World Health Organization predicts that the number of 
osteoporotic fractures in men and women is certain to increase 
by more than 3-fold over the next fifty years [9]. There has 
been a definitive increase in awareness of the disease in 
developing countries, where accessibility to DXA scanning is 
limited. The most recent data portraying the global distribution 
of DXA machines highlights this inaccessibility: only 450 
DXA machines in China, for a population of 1.3 billion (1 
per 289,000) [10]. Only 34 machines exist in Indonesia, for a 
population of 237 million (1 per 7 million) and 161 machines 
in Chile, for a population of 17.62 million (1 per 109,000) 
[10].  The United States has approximately 35.8 DXA machines 
per million of the population (1 per 28,000), compared to a 
mere 2.3 machines per million of the population in Peru (1 per 
435,000) [10]. These examples illustrate the inequity of DXA 
scanner distribution around the world, directly correlating to 
an inequity of osteoporosis diagnoses.
DXA scanning, while it is the current model for determining 
patient bone health, is a relatively new procedure, which 
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began clinical use in the mid-1980’s. The evolution of bone-
scanning technology has significantly changed from early 
methods of X-ray detection (requiring 30% bone loss for 
visual recognition) to photon absorptiometry methods and 
finally to DXA technology, in which patient bone health can 
be recognized and classified for BMD as normal, osteoporotic, 
or osteopenic [11]. However, the fulcrum regarding the 
advances in technology, which have provided quick and 
accurate diagnoses for patient bone health, resides with the 
inaccessibility of this technology. Additionally, maintaining a 
DXA may be expensive.  The latest DXA scanners, equipped 
with the World Health Organization Fracture Risk Assessment 
(FRAX) calculation tool, cost over $100,000 U.S. per 
machine, making them inaccessible to a majority of the global 
population [8]. As a result of the economic obstacles faced by 
developing nations, there is a need to establish an alternative 
form of diagnostic treatment for metabolic diseases, which 
may be found by examining specific bone turnover markers 
within the blood serum.
Bone Turnover Markers
A DXA scan measures and records the density of the bone, 
which is dependent upon the activity levels of osteoclasts 
and osteoblasts. Osteoclasts remove mineralized bone tissue, 
primarily protein and collagen, by secreting an acid containing 
specialized proteinases that degrade the organic matrix, which 
is re-circulated into the bloodstream [12]. Osteoblasts add 
protein and collagen back to bone to create the bone matrix 
[13,14]. The activity of these cells correlates to certain 
biochemical markers in the blood, known as bone turnover 
markers (BTMs) [15]. Therefore, the relative concentrations 
of BTMs may effectively contribute to the diagnosis of 
osteoporosis. Serum pyridinoline cross-links (s-PYD) and 
serum osteocalcin (s-OC) are known BTMs that correlate to 
osteoclast and osteoblast activity. They are among the least 
expensive assays to obtain, making them the most globally 
accessible. BTMs can be measured with specific blood assays 
through a simple blood draw [16].
DXA machine availability in developing countries is simply 
too scarce to provide adequate screening for bone health. The 
potential for diagnosing osteoporosis through a more simple 
blood draw and serum analysis, instead of through use of a 
DXA scan, provides important implications for the global 
community, especially in regions where DXA scanning is not 
available. Blood testing is already widely used around the 
world, relatively easy and does not require expensive on-site 
machinery. Blood samples could be sent to centralized medical 
laboratories for analysis and then these data could be relayed 
back to where it originated.
The purpose of this study was to determine the diagnostic 
potential of various BTMs—specifically serum OC and serum 
PYD—with the intention of creating a cost-effective and 
predictive algorithm for the diagnosis of osteoporosis. 
Methods
Subject Enrollment
Over a three-year period, 555 subjects were recruited to 
participate in a study to determine the bone health of Orange 
County residents. Of these 555 subjects, data from 226 
individuals were included in this study. This population 
represented individuals belonging to four self-described ethnic 
groups: Asian, African American, Caucasian and Hispanic. 
After the subjects were categorized by ethnicity and sex, they 
were then allocated to age divisions where potential changes in 
bone health were expected. An individual’s bone health peaks 
around the age of 30 years [17]. After this age, the process 
of bone remodeling begins to favor resorption and bone mass 
gradually decreases [18]. Additionally, when women begin 
menopause at around the age of 50, their bone mass decreases 
at a much quicker rate than premenopausal declines [19-21].
Sample Demographics
The 226 subjects that met the inclusion criteria (no prior history 
of bone disorders, no bisphosphonates) for this study resided 
in Orange County, California. The majority were female 
(76.1%), older than 50 years of age (59.5%), with normal BMI 
values between 18.5 and 24.9 (57.5%). The average height and 
weights of the participants were 65.5 inches and 149.2 pounds 
with standard deviations of 3.5 inches and 31.2 pounds. 
Moreover, the average serum OC and serum PYD levels were 
8.7 nmol/L and 6.6 nmol/L with standard deviations of 3.5 and 
3.3. Slightly over half (55.3%) had healthy T-scores greater 
than or equal to -1, 41.6% had T-scores between -1 and -2.5 
and 3.1% had scores below -2.5, reflecting the diagnosis of 
osteoporosis. Descriptive analysis of the sample demographics 
and lab characteristics are presented in Table 1.
Procedure and Tests Performed
Subjects were randomly recruited from the general Orange 
Characteristic: n(%):
1) Age (years):
16-30 27 (11.9)
31-50 56 (24.8)
51-70 110 (48.7)
Greater than 70 24 (10.8)
2) Sex:
Female 172 (76.1)
Male 54 (23.9)
3) BMI
Less than 18.5 9 (4.0)
18.5-24.9 130 (57.5)
25-29.9 65 (28.8)
More than 30 22 (9.7)
4) Height (inches) 65.5 (3.5)
5) Weight (pounds) 149.2 (31.2)
6) Serum OC  (nmol/L) 8.7 (3.5)
7) Serum PYD (nmol/L) 6.6 (3.3)
8) T-score
-2.5 and below 7 (3.1)
-1 to -2.5 94 (41.6)
-1 and above 125 (55.3)
Table 1: Summary statistics of demographics and lab 
characteristics of the study participants (N=226).
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County population after review and approval of the study 
protocol by the Chapman University Institutional Review 
Board. The subjects responded to advertisements in papers, 
flyers sent to athletic and religious organizations, posters 
presented in the windows of local stores, advertisements in 
newspapers, advertisements on various Internet websites 
and through direct contact. Demographic questions allowed 
the subjects to categorize themselves by ethnicity, sex and 
age. They also answered lifestyle questions, which were 
necessary to calculate the FRAX values [22]. After obtaining 
an informed consent, the subjects were sent to Marathon 
Medical Group clinic, heights and weights were measured, 
blood was drawn and DXA analyses were conducted. 
The DXA scan for each subject included analysis of the 
femoral neck, trochanter and the intertrochanteric regions 
of the femoral diaphysis, which taken together constituted 
the total hipbone mineral content. The anterio-posterior 
lumbar spine was also assessed. The DXA scans were 
performed using two effective energies of 38kW and 70kW. 
The BMD data obtained from the DXA reports were utilized 
to determine each individual’s T-Score. By convention, a 
T-score of -1 or above is considered normal bone density, a 
score between -1.0 and -2.5 indicates an osteopenic state and 
a score of -2.5 or below is indicative of osteoporosis [23,24]. 
The blood samples taken at Marathon Medical Group clinic 
were sent to Quest Diagnostics and Chapman University for 
analysis of specific biomarkers.
Participants’ body mass index (BMI) scores were also obtained. 
After the collection and organization of data, multivariate 
statistical analyses were performed. 
Statistical Analysis
Demographic and lab characteristics of the study participants 
were analyzed through frequency, means and standard deviation 
estimations. We implemented logistic regression modeling 
to find the best classification algorithm for osteoporosis. All 
calculations and model building steps were carried out using R 
statistical language.  
Results
Logistic regression modeling
We implemented exhaustive logistic regression modeling 
by comparing all possible univariate and multivariate 
models with and without interactions to identify the model 
with the best classification properties with respect to the 
presence and absence of osteoporosis given the collected 
set of covariates. 
The best classification model that was created included main 
effects of serum OC with effect size of 0.39 and p-value of 
0.001, serum PYD with effect size of -0.45 and p-value of 0.09 
and age with effect size of 0.08 and p-value of 0.03. Inclusion of 
the marginally significant variable of serum PYD in the model 
was justified by the increase of the area under the Receiver 
Operating Characteristic (ROC) curve (from 0.89 to 0.93) and 
a decrease in the Akaike Information Criterion (AIC) statistic 
(from 54.15 to 52.41). Even though unimportant for the 
classification purposes of the model, the interpretation of the 
logistic regression coefficients shows that a one unit increase 
in the serum OC and serum PYD levels were associated with 
47% increase and 37% decrease in the odds of osteoporosis 
respectively. Similarly, a one-year increase in age is associated 
with an 8% increase in the odds of osteoporosis. Detailed 
summary results from the best classification model that we 
identified are shown in Table 2 and Figure 1.
Classification of algorithm
The proposed classification algorithm that optimally assigns 
people to either the group with or without osteoporosis, given 
the values of serum OC, serum PYD and age is based on the 
model presented in Table 2. This model predicts log-odds of 
having osteoporosis and is given by:
 
Equation 1
Similarly, the model predicted probability of having 
osteoporosis is:
    
Equation 2
Figure 1: ROC Curve depicting the best classification model 
found through analysis of age, serum OC and serum PYD. 
An area under the curve (AUC) of 0.93 was calculated for 
this model. The AUC is arguably the best way to summarize 
the performance of a predictive model, of which an AUC 
close to 1 indicates a highly predictive model and a value at 
or below 0.5 indicates a model that is not predictive.
Variable Estimate Odd Ratio SE Z-value P-value
Intercept -9.20 - 2.69 -3.41 0.0006
Serum OC 0.39 1.47 0.12 3.19 0.001
Serum PYD -0.45 0.63 0.27 -1.70 0.09
Age in years 0.08 1.08 0.03 2.22 0.03
Table 2: Summary results from the best classification logistic 
regression model.
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The values generated by Equation 2 are between 0 and 1 
and subjects with high model predicted probabilities were 
assigned to the group with osteoporosis and the rest to the 
control group. The threshold that separated high and low 
predicted probabilities was chosen optimally so that there 
was simultaneously maximized sensitivity and specificity of 
the classification algorithm. The threshold that maximized the 
sum of the sensitivity and specificity was 0.035. It achieved 
sensitivity of 1.0 and specificity of 0.83 and it is denoted with 
a diamond on the ROC curve presented in Figure 1. Thus, the 
model predicted disease status  given serum OC, serum PYD 
and age was assigned according to the following classification 
rule:
          Equation 3
Discussion
Analysis of bone turnover markers indicative of bone 
formation and bone resorption proved to be encouraging in the 
creation of a diagnostic algorithm (Chapman Bone Algorithm) 
for the detection of osteoporosis. When analyzed with age, 
concentrations of serum OC and PYD had a direct correlation 
to a T-score of -2.5 or lower. Based on the significant 
outcome of the multivariate statistical analyses, as well as 
the extensively-studied physiology of the bone remodeling 
process, we believe that the variables of age, serum OC 
and serum PYD are sufficient in detecting osteoporosis. 
We initially expected that BMI would be a significant 
contributor to the Chapman Bone Algorithm (CBA). Women 
with low BMIs are characterized as having weaker bones that 
are more susceptible to fractures, while the bones of women 
with high BMIs must be proportionately stronger in order to 
support a greater body mass [25]. The analysis of BMI in this 
data set, however, was not statistically significant (P> 0.05). 
Knowing that osteoporosis affects females 4 times more than 
males, on cursory examination it might appear that biological 
sex was overlooked in the CBA [26,27]. While there is a high 
correlation between sex and bone-health predictors of age, OC 
and PYD, our statistical model examined direct predictors and 
not simply correlational relationships. For this reason, sex is 
not explicit in the Chapman Bone Algorithm.
In future studies, patient information will be collected using 
the same multivariate statistical analyses as described in 
this study on larger data sets containing a greater number of 
confirmed diagnoses of osteoporosis. Ultimately, the goal of 
these future studies will be to test the CBA’s reliability on a 
larger data set. Additionally, the utilization of more variables 
or the testing of other bone turnover markers could contribute 
to a stronger predictive model.
Significance of the CBA
General implications of the CBA lie within the algorithm’s 
nature for quick and cost-effective analysis of bone health, 
which can be of particular benefit in low socioeconomic 
conditions of developed nations or within developing 
communities. Disparities in healthcare access are evident in 
many global locations, even outside of prototypical Western 
cultures (e.g. United States of America), such as the existing 
disparity between countries like Israel and Egypt. Per the CIA 
World Factbook, Israel (7.80% GDP) ranks 60 spots higher 
in global rankings than Egypt (5.60%) in relative promotion, 
restoration and maintenance of health (indicated by health 
expenditures as a percentage of country GDP) [28]. Given 
this information, Israel would be an example of a non-Western 
nation with relatively high health standards and priority in 
comparison to neighboring Egypt. Israel is home to Holocaust 
survivors, who were typically malnourished at an early age, 
often a precursor for early onset osteoporosis [29]. Yet, 
impacts from malnutrition on bone health in Israel are less 
adverse due to higher healthcare priority and accessibility [29]. 
However, it is unlikely that similar testing practices would be 
conducted in countries with higher rates of early malnutrition 
and community-wide poverty, such as Africa and Southeast 
Asia [30].
Aside from being a chronic condition that affects those with 
low BMD, osteoporosis has also shown comorbid association 
with various other chronic health conditions, posing serious 
implications on the metabolic bone disease. In conjunction 
with HIV, however, limited research on its relationship with 
HIV has been conducted. The potential correlation between 
HIV prevalence and metabolic bone disease prevalence is 
largely unknown, but it may be due to the fact that areas with 
high HIV prevalence (e.g. Africa) also have limited resources 
for health screening [31]. Potential comorbid diseases 
with osteoporosis listed in the literature include ischemic 
cardiovascular disease (CVD) and HIV. Common factors 
between the CVD and osteoporosis are estrogen deprivation 
in women, smoking, low physical activity, or diabetes [32]. 
Due to the severity of these primitive potential relationships, 
establishing medical practices for determining early onset 
of osteoporosis, among other chronic metabolic conditions, 
is imperative to eliminating health disparities in regions 
with limited resources and lack of modern medical practice 
feasibility.
Although it may currently be the most common way to diagnose 
osteoporosis, DXA scanning is still largely inconvenient, 
inaccessible and requires expensive instrumentation 
worldwide. We are suggesting an alternative diagnosis for this 
bone disease, in which quantitative, statistically-significant 
risk factors are utilized in the CBA to determine an individual’s 
bone health. We imagine the CBA to not only serve in the 
evaluation of osteoporosis but to also provide periodic 
evaluations to assess the efficacy of a treatment plan. Instead 
of relying on expensive DXA equipment, the Chapman Bone 
Algorithm utilizes easily obtained and commonly assayed 
biomarkers. We believe the CBA will have similar functionality 
to the American Heart Association’s 10-year risk calculator 
for developing atherosclerotic cardiovascular disease; which 
indicates the likelihood of developing atherosclerosis [33]. It is 
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likely that the CBA will be an economical, effective and vastly 
more accessible diagnostic option for remote and developing 
populations and that healthcare providers around the world 
can use this algorithm with confidence.
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